News Agency
The Times

First patient treated with Cu-67 SAR-Bombesin in theranostic prostate cancer trial

  • Written by PR Newswire
First patient treated with Cu-67 SAR-Bombesin in theranostic prostate cancer trial

SYDNEY, Oct. 3, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce the dosing of the first patient in its theranostic 64Cu/67Cu SAR-Bombesin...

Read more: First patient treated with Cu-67 SAR-Bombesin in theranostic prostate cancer trial

Why Commercial Waste Management Is Important For Modern Businesses

Businesses across many industries generate large amounts of waste every day through operations, packaging, manufacturing, customer activity, and general workplace use. Many organisations now depend on professional commercial waste management services to maintain cleaner workplaces, improve operational efficiency, and support environmentally... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion